Saul N. Faust

39.2k total citations · 1 hit paper
170 papers, 4.3k citations indexed

About

Saul N. Faust is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Saul N. Faust has authored 170 papers receiving a total of 4.3k indexed citations (citations by other indexed papers that have themselves been cited), including 93 papers in Epidemiology, 48 papers in Microbiology and 38 papers in Infectious Diseases. Recurrent topics in Saul N. Faust's work include Pneumonia and Respiratory Infections (66 papers), Bacterial Infections and Vaccines (46 papers) and Respiratory viral infections research (38 papers). Saul N. Faust is often cited by papers focused on Pneumonia and Respiratory Infections (66 papers), Bacterial Infections and Vaccines (46 papers) and Respiratory viral infections research (38 papers). Saul N. Faust collaborates with scholars based in United Kingdom, United States and Australia. Saul N. Faust's co-authors include Michael Levin, Alasdair Munro, Stuart C. Clarke, Robert S. Heyderman, Johanna M. Jefferies, Odile B. Harrison, Robert Goldin, Rebecca A. Gladstone, Zoltán Lászik and Charles T. Esmon and has published in prestigious journals such as New England Journal of Medicine, Angewandte Chemie International Edition and SHILAP Revista de lepidopterología.

In The Last Decade

Saul N. Faust

162 papers receiving 4.2k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Nirsevimab for Prevention of Hospitalizations Due to RSV in Infants

2023 175 citations Saul N. Faust et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Saul N. Faust United Kingdom	33	2.3k	861	783	544	530	170	4.3k
Chiara Azzari Italy	38	2.7k 1.2×	733 0.9×	540 0.7×	589 1.1×	387 0.7×	251	5.1k
Christoph Berger Switzerland	36	1.9k 0.9×	1.0k 1.2×	354 0.5×	757 1.4×	356 0.7×	234	4.6k
Elizabeth Molyneux Malawi	47	1.7k 0.8×	1.2k 1.4×	729 0.9×	320 0.6×	722 1.4×	226	6.9k
Flor M. Muñoz United States	44	3.8k 1.7×	1.7k 2.0×	1.2k 1.6×	672 1.2×	231 0.4×	205	6.8k
James D. Kellner Canada	36	2.2k 1.0×	743 0.9×	739 0.9×	448 0.8×	420 0.8×	146	4.5k
Ping‐Ing Lee Taiwan	43	3.0k 1.3×	2.8k 3.2×	442 0.6×	395 0.7×	521 1.0×	238	7.0k
Fred Zepp Germany	42	2.4k 1.1×	891 1.0×	1.4k 1.8×	1.0k 1.9×	705 1.3×	198	5.5k
Jun‐ichi Kadota Japan	43	2.2k 1.0×	1.0k 1.2×	345 0.4×	738 1.4×	774 1.5×	369	6.5k
Petros I. Rafailidis Greece	47	3.3k 1.4×	1.9k 2.2×	211 0.3×	472 0.9×	799 1.5×	116	7.7k
Russell W. Steele United States	38	1.7k 0.7×	890 1.0×	399 0.5×	836 1.5×	294 0.6×	229	4.7k

Countries citing papers authored by Saul N. Faust

Since Specialization

Citations

This map shows the geographic impact of Saul N. Faust's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Saul N. Faust with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Saul N. Faust more than expected).

Fields of papers citing papers by Saul N. Faust

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Saul N. Faust. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Saul N. Faust. The network helps show where Saul N. Faust may publish in the future.

Co-authorship network of co-authors of Saul N. Faust

This figure shows the co-authorship network connecting the top 25 collaborators of Saul N. Faust. A scholar is included among the top collaborators of Saul N. Faust based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Saul N. Faust. Saul N. Faust is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Highmore, Callum, et al.. (2025). Identification and antimicrobial resistance profiling of Pseudomonas aeruginosa using multi-excitation Raman spectroscopy and computational analytics. PubMed. 3(1). 74–74. 1 indexed citations

Moyses, Helen, Kordo Saeed, Paul R. Afolabi, et al.. (2022). Body mass index and clinical outcome of severe COVID-19 patients with acute hypoxic respiratory failure: Unravelling the “obesity paradox” phenomenon. Clinical Nutrition ESPEN. 51. 377–384. 5 indexed citations

Waldron, Cherry-Ann, Emma Thomas‐Jones, Jolanta Bernatoniene, et al.. (2022). Biomarker-guided duration of Antibiotic Treatment in Children Hospitalised with confirmed or suspected bacterial infection (BATCH): protocol for a randomised controlled trial. BMJ Open. 12(1). e047490–e047490. 3 indexed citations

Bielicki, Julia, David Dunn, Saul N. Faust, et al.. (2021). Amoxicillin duration and dose for community-acquired pneumonia in children: the CAP-IT factorial non-inferiority RCT. Health Technology Assessment. 25(60). 1–72. 7 indexed citations

Driessens, Corine, Alexander W. Tarr, William L. Irving, et al.. (2021). Immunocompromised children and young people are at no increased risk of severe COVID-19. Journal of Infection. 84(1). 31–39. 20 indexed citations

Swanson, Phillip A., Marcelino Padilla, Kelly McGlinchey, et al.. (2021). AZD1222/ChAdOx1 nCoV-19 vaccination induces a polyfunctional spike protein–specific T _H 1 response with a diverse TCR repertoire. Science Translational Medicine. 13(620). eabj7211–eabj7211. 59 indexed citations

Bate, Jessica, Ray Borrow, Julia Chisholm, et al.. (2019). Thirteen-Valent Pneumococcal Conjugate Vaccine in Children With Acute Lymphoblastic Leukemia: Protective Immunity Can Be Achieved on Completion of Treatment. Clinical Infectious Diseases. 71(5). 1271–1280. 9 indexed citations

Cleary, David, Denise E. Morris, Karen L. Osman, et al.. (2018). Pneumococcal vaccine impacts on the population genomics of non-typeable Haemophilus influenzae. Microbial Genomics. 4(9). 19 indexed citations

Saavedra‐Lozano, Jesús, Oana Falup‐Pecurariu, Saul N. Faust, et al.. (2017). Bone and Joint Infections. The Pediatric Infectious Disease Journal. 36(8). 788–799. 137 indexed citations

10.

Jefferies, Johanna M., et al.. (2015). Nasopharyngeal Bacterial Carriage in the Conjugate Vaccine Era with a Focus on Pneumococci. Journal of Immunology Research. 2015. 1–8. 21 indexed citations

11.

Whittaker, Robert, Rebecca Anderson, Andrew Tuck, et al.. (2014). Evaluation of swabbing methods for estimating the prevalence of bacterial carriage in the upper respiratory tract: a cross sectional study. BMJ Open. 4(10). e005341–e005341. 20 indexed citations

12.

Khatami, Ameneh, Matthew D. Snape, Clarissa Oeser, et al.. (2013). Phase II Study of a Three-dose Primary Vaccination Course of DTPa-IPV/Hib-MenC-TT Followed by a 12-month Hib-MenC-TT Booster in Healthy Infants. The Pediatric Infectious Disease Journal. 32(6). 675–681. 3 indexed citations

13.

Iro, Mildred A., et al.. (2013). Varicella Zoster Virus Central Nervous System Immune Reconstitution Inflammatory Syndrome Presenting in a Child. The Pediatric Infectious Disease Journal. 32(11). 1283–1284. 5 indexed citations

14.

Walker, Woolf, Matthew D. Snape, Clarissa Oeser, et al.. (2011). A 1-year follow-on study from a randomised, head-to-head, multicentre, open-label study of two pandemic influenza vaccines in children. Health Technology Assessment. 15(45). v–vi, xi. 4 indexed citations

15.

Daniëls, Tessa M. John, Eva Galiza, et al.. (2010). Immunogenicity and Reactogenicity of a 13-Valent-pneumococcal Conjugate Vaccine Administered at 2, 4, and 12 Months of Age. The Pediatric Infectious Disease Journal. 29. 4 indexed citations

16.

Marsh, Peter, Alastair B. Monk, A. Pallett, et al.. (2009). Detection of uncultured organisms in paediatric bone and joint infections by a multiplex real-time PCR panel. ePrints Soton (University of Southampton). 1 indexed citations

17.

Galiza, Eva, Daniel A. Scott, Scott D. Patterson, et al.. (2009). Immunogenicity of booster doses of 13-valent pneumococcal conjugate and Hib/MenC vaccines given at 12 months of age in the UK. ePrints Soton (University of Southampton). 9 indexed citations

18.

Zenz, Werner, Michael Levin, Sergio Fanconi, et al.. (2004). Use of recombinant tissue plasminogen activator in children with meningococcal purpura fulminans: A retrospective study*. Critical Care Medicine. 32(8). 1777–1780. 35 indexed citations

19.

Shenoy, Mohan, David Luyt, Christine Pierce, et al.. (2001). Accident and emergency/Intensive care. Archives of Disease in Childhood. 84(90001). 10a–13. 1 indexed citations

20.

Pollard, Andrew J., Saul N. Faust, & Michael Levin. (1998). Meningitis and Meningococcal Septicaemia. Journal of the Royal College of Physicians of London. 32(4). 319–328. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact